For Patients and Families For Healthcare Professionals

Are you a healthcare professional?

I am

Go back

Knopp Biosciences
  • Pipeline
  • Dexpramipexole
    • Market Landscape
  • Kv7 Platform
    • KCNQ2-EE Mutation
  • Knopp Biosciences
  • News & Resources
  • For Patients and Families
social-link social-link social-link
Inquire

News and Resources

Dexpramipexole Kv 7 Company News
  • All
  • Presentations
  • Publications
01.14.21

Knopp Biosciences Announces Positive Top-Line Results from the Phase 2 EXHALE Trial of Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma

Discover this News
01.04.21

Dexpramipexole Targets Eosinophilic Inflammation

Discover this News
09.16.20

Knopp Biosciences Completes Enrollment in Phase 2 Trial of Oral Dexpramipexole in Eosinophilic Asthma

Discover this News
12.02.19

Knopp Biosciences and University of Leicester Announce Update on Planned Phase 2 Clinical Trial of Oral Dexpramipexole in Severe Eosinophilic Asthma

Discover this News
07.09.19

Dexpramipexole Responsiveness is Increased in Eosinophilic Subjects

Discover this News
07.09.19

Developing Dexpramipexole for the Treatment of Eosinophilic Disorders

Discover this News
07.09.19

Knopp Biosciences to Present Clinical Data for Dexpramipexole at 11th Biennial Symposium of the International Eosinophil Society

Discover this News
04.24.19

Knopp Biosciences Receives FDA Orphan Drug Designation for Dexpramipexole for Treatment of Hypereosinophilic Syndrome

Discover this News
03.20.19

Knopp Biosciences Enters Collaboration with Leading UK Investigators to Commence Phase 2 Clinical Trial of Dexpramipexole in Severe Eosinophilic Asthma

Discover this News
1 2
social-link social-link social-link

Learn More About the Unmet Needs We Strive to Address

Read Our Blog

Keep Up with Knopp, See What We Are Doing Next.




    Knopp Biosciences
    • Dexpramipexole
      • Market Landscape
    • Kv7 Platform
      • KCNQ2-EE Mutation
    • Pipeline
    • Knopp Biosciences
    • News & Resources
    Inquire +1 412-488-1776
    © Copyright 2021 Knopp Biosciences LLC. All Rights Reserved
    Privacy Policy Terms of Use
    social-link social-link social-link

    Knopp Disclaimer

    Knopp’s pipeline consists of investigational drug products that have not been approved by the U.S. Food and Drug Administration. These investigational drug products are undergoing clinical study to verify their safety and effectiveness.

    This site uses cookies as explained in our Privacy Policy. If you agree to our use of cookies, please accept, alternatively, you can change your settings and decline.